Company news

TMS Co., Ltd. news in 2026

TMS Co., Ltd.'s news releases, calls and decks from 2026, newest first.

View company

Notice of Completion of PMDA’s 14-Day Review Period for the TMS-008 Phase IIa Clinical Trial

October 15, 2026

Notice of Submission of a Clinical Trial Plan Notification for a Phase IIa Clinical Trial of TMS-008 for Acute Kidney Injury

September 30, 2026

(Correction) Notice of Partial Correction to “Presentation Materials”

August 25, 2026

Non-consolidated Financial Results for the Six Months Ended June 30, 2026 [Japanese GAAP]

August 14, 2026

Decks in 2026